2007
DOI: 10.1039/b702538f
|View full text |Cite
|
Sign up to set email alerts
|

Antibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
129
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 178 publications
(135 citation statements)
references
References 16 publications
6
129
0
Order By: Relevance
“…[166][167][168] In a recent study, antibody-conjugated magnetic Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles with doxorubicin (DOX) were synthesized for the simultaneous targeted detection and treatment of breast cancer. [169] DOX and magnetic nanoparticles were incorporated into PLGA nanoparticles, with DOX serving as an anticancer drug and Fe 2 O 3 nanoparticles used as an imaging agent (Fig. 19).…”
Section: Magnetic Resonance Imagingmentioning
confidence: 99%
“…[166][167][168] In a recent study, antibody-conjugated magnetic Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles with doxorubicin (DOX) were synthesized for the simultaneous targeted detection and treatment of breast cancer. [169] DOX and magnetic nanoparticles were incorporated into PLGA nanoparticles, with DOX serving as an anticancer drug and Fe 2 O 3 nanoparticles used as an imaging agent (Fig. 19).…”
Section: Magnetic Resonance Imagingmentioning
confidence: 99%
“…In this study, the cytotoxicity of four different treatments (IDNP w/o laser treatment, AIDNP w/o laser treatment, IDNP w/ laser treatment and AIDNP w/ laser treatment) were investigated. Cells were seeded into a 96-well plate on the first day, and after overnight incubation they were exposed to different treatments The slow sustained release of DOX from targeted AIDNP and the biphasic behavior of the release profile observed in both AIDNP and IDNP are consistent with other literature reports as well (Yang 2007;Chittasupho 2009;. The two phases of DOX release correspond to an initial burst release, followed by a sustained slow release.…”
Section: Introductionsupporting
confidence: 71%
“…This nanocomposite has been employed for the concurrent targeted iagnosis and management of breast cancer [76] . Recently, multimodal nano-materials have been exploited for immediate diagnosis and therapy.…”
Section: Mri and Cancer Therapymentioning
confidence: 99%